ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Faeth Therapeutics
32.00
-0.1000
-0.31%
盘前:
32.00
0.0000
0.00%
07:02 EDT
成交量:
43.39万
成交额:
1,409.67万
市值:
8.25亿
市盈率:
-0.23
高:
34.44
开:
33.00
低:
31.29
收:
32.10
52周最高:
37.90
52周最低:
7.45
股本:
2,577.88万
流通股本:
81.17万
量比:
1.29
换手率:
53.45%
股息:
- -
股息率:
- -
每股收益(TTM):
-141.6499
每股收益(LYR):
-16.7239
净资产收益率:
-195.26%
总资产收益率:
-20.79%
市净率:
4.77
市盈率(LYR):
-1.91
数据加载中...
总览
公司
新闻资讯
公告
FDA授予抗癌药物快速通道资格后,Faeth Therapeutics股价上涨
路透中文
·
08/17
Faeth Therapeutics:晚期子宫内膜癌2期试验顶线数据预计2026年底公布
美股速递
·
08/17
美国研究综述-美国铁塔公司、H.B.富勒公司、TD Synnex
路透中文
·
06/26
Sensei Biotherapeutics:Piktor治疗HR+/HER2-晚期乳腺癌的1B/2期中期数据预计2027年公布
美股速递
·
06/15
Sensei Biotherapeutics:Piktor治疗晚期子宫内膜癌的II期关键数据预计2026年下半年公布
美股速递
·
06/15
Sensei Biotherapeutics任命Anand Parikh为董事长、总裁兼首席执行官,自2026年6月12日起生效
美股速递
·
06/15
Sensei Biotherapeutics更名为Faeth Therapeutics,全力推进口服抗癌疗法Piktor
美股速递
·
06/15
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/FTH/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":32,"timestamp":1787342400000,"preClose":32.1,"halted":0,"volume":433893,"hourTrading":{"tag":"盘前","latestPrice":32,"preClose":32,"latestTime":"07:02 EDT","volume":5,"amount":160,"timestamp":1787569349699,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0031152647975078323,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"盘前交易","change":-0.1,"latestTime":"08-24 08:32:54 EDT","open":33,"high":34.44,"low":31.29,"amount":14096734.056852002,"amplitude":0.098131,"askPrice":37.44,"askSize":100,"bidPrice":26.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":32,"preHourTrading":{"tag":"盘前","latestPrice":32,"preClose":32,"latestTime":"07:02 EDT","volume":5,"amount":160,"timestamp":1787569349699,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":32,"preClose":32,"latestTime":"19:30 EDT","volume":1722,"amount":55104,"timestamp":1787355006301,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2941560704132655},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.2941560704132655,"shares":25778800,"dividePrice":0,"high":34.44,"amplitude":0.098131,"preClose":32.1,"low":31.29,"week52Low":7.45,"pbRate":"4.77","week52High":37.9,"institutionHeld":0,"latestPrice":32,"eps":-141.6499,"divideRate":0,"volume":433893,"delay":0,"ttmEps":-141.6499,"open":33,"prevYearClose":10.67,"prevWeekClose":32,"prevMonthClose":27.24,"prevQuarterClose":25,"fiveDayClose":32.34,"twentyDayClose":28.29,"sixtyDayClose":16.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盘前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1785902400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-08-21","current":-0.225909,"percent":0.204545,"low":-5.053534,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"high":-0.105707,"avg":-3.520013,"sd":1.147061,"marketCap":829477642},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642}],"updateTime":1787571325153},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660448760","title":"FDA授予抗癌药物快速通道资格后,Faeth Therapeutics股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448760","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448760?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 20:19","pubTimestamp":1786969153,"startTime":"0","endTime":"0","summary":"BUZZ-FDA授予抗癌药物快速通道资格后,Faeth Therapeutics股价上涨8月17日-** 抗癌药物开发商 Faeth Therapeutics(FTH.O)的股价在盘前交易中上涨 2%,至 33 美元** 该公司表示,美国食品药品监督管理局(FDA)已授予其实验性双药疗法PIKTOR(联合化疗)快速通道资格,该疗法适用于部分晚期或复发性子宫内膜癌患者,子宫内膜癌是一种起源于子宫内膜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137671951","title":"Faeth Therapeutics:晚期子宫内膜癌2期试验顶线数据预计2026年底公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1137671951","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137671951?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 19:33","pubTimestamp":1786966420,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics宣布,其针对晚期子宫内膜癌的2期临床试验顶线数据,预计将于2026年底揭晓。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646343783","title":"美国研究综述-美国铁塔公司、H.B.富勒公司、TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646343783","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646343783?lang=zh_cn&edition=fundamental","pubTime":"2026-06-26 15:07","pubTimestamp":1782457653,"startTime":"0","endTime":"0","summary":"美国研究综述-美国铁塔公司、H.B.富勒公司、TD Synnex路透6月26日-周五,华尔街的证券分析师们调整了多家在美国上市公司的评级和目标股价,其中包括美国铁塔公司、H.B.富勒公司和TD Synnex。重点摘要* 美国铁塔公司AMT.N:加拿大皇家银行将其评级从“行业表现”上调至“跑赢大盘”* H.B.富勒公司 FUL.N:摩根大通将评级从“中性”上调至“超配”* TD SynnexSNX.N:RBC将目标价从315美元上调至340美元以下是路透周五报导的针对美国公司的研究动向摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4T42Y0EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0000B7K699.USD","IE00B19Z3581.USD","LU0154245756.USD","LU2360107168.USD","MRNY","BK4215","IE00BKVL7J92.USD","LU1059921491.USD","LU2236285917.USD","IE00BSNM7G36.USD","LU2250418816.HKD","LU0109392836.USD","BK4139","LU1978683503.SGD","LU1868837300.USD","LU0757428866.USD","IE000M9KFDE8.USD","LU1551013342.USD","LU1868837136.USD","LU1815333072.USD","LU2087621335.USD","BK4566","LU1720051017.SGD","SG9999000418.SGD","IE00BJT1NW94.SGD","IE000SO60NU8.SGD","BK4553","SG9999013999.USD","LU0256331488.USD","LU1496350502.SGD","LU0154236417.USD","IE00BN8TJ469.HKD","LU0889566641.SGD","IE000WAW04H5.SGD","LU2471134523.USD","BK4592","LU2458330243.SGD","BK4109","LU1066051811.HKD","LU1221951046.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU0444973449.USD","LU0859254822.USD","LU0942090050.USD","IE00BGHQF631.EUR","LU0994945656.USD","LU2592432038.USD","LU0061475181.USD","SG9999002232.USD","LU1162221912.USD","LU1852331112.SGD","LU2133065610.SGD","IE00BZ199S13.USD","LU1069344957.HKD","LU1894683264.USD","LU0157215616.USD","LU0082616367.USD","LU0444971666.USD","LU1548497426.USD","MRNX","LU1267930656.SGD","BK4564","BK4518","LU0056508442.USD","BK4501","IE00B2B36J28.USD","LU1839511570.USD","IE00BVYPNW00.USD","LU1003077747.HKD","LU2896262040.SGD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU2028103732.USD","PEP","LU0702159343.USD","LU0287143357.SGD","LU2290526834.HKD","LU0158827948.USD","LU0122379950.USD","LU2089984988.USD","BK4534","LU1121112475.USD","IE00BQXX3C00.GBP","LU1048596156.SGD","OVV","LU1061106388.HKD","SG9999002224.SGD","BK4585","LU0950375773.USD","LU1935042991.SGD","LU0426412945.USD","LU0708995666.HKD","LU0320765646.SGD","BK4543","LU0079474960.USD","ESS","LU1854103824.USD","LU1506573853.SGD","BK4140","IE00B42XCP33.USD","IE00BK4W5L77.USD","LU2756315664.SGD","LU0070217475.USD","LU2471134952.CNY","LU0345770308.USD","LU2298322129.HKD","IE0002141913.USD","BK4581","IE00BJJMRZ35.SGD","LU0964807845.USD","LU1674673691.USD","BK4575","LU2129689514.USD","LU2023250504.SGD","LU2413666426.HKD","LU1366333091.USD","IE00B7SZLL34.SGD","LU1868836914.USD","LU0943347566.SGD","LU2750360997.AUD","BK4533","LU2112291526.USD","LU2360107325.USD","LU0006061336.USD","LU0289960550.SGD","LU0432979614.USD","BK4550","LU2505996509.AUD","AR","LU0096364046.USD","LU0061474960.USD","BK4209","BK4559","LU2506951958.HKD","LU1066051498.USD","LU2430703178.SGD","LU2213496289.HKD","LU0072462343.USD","IE000MB6IJN5.SGD","LU0238689110.USD","LU2471134879.HKD","BK4527","IE0034390439.USD","LU0347712357.USD","LU1221951129.SGD","LU2054465674.USD","LU0124384867.USD","LU1914381329.SGD","IE000BZT7R73.USD","KWR","BK4187","LU0820562030.AUD","LU1261432733.SGD","LU2468319806.SGD","FTH","IE00B4R5TH58.HKD","LU2430703251.USD","IE000F7OJYX1.SGD","LU0011850046.USD","LU0683600562.USD","IE00B19Z3B42.SGD","LU1815336760.USD","LU1721428933.USD","LU0868494617.USD","04336","LU2506951875.HKD","IE0002270589.USD","LU1861215975.USD","IE00B19Z6F94.USD","SG9999001440.SGD","JNJ","AVXX","LU0081259029.USD","LU1917777945.USD","GB00BDT5M118.USD","LU1868836591.USD","LU1989773731.SGD","BK4588","BK4603","LU2023250843.SGD","LU2750360641.GBP","SG9999001424.SGD","SGXZ57979304.SGD","LU1929549753.HKD","IE00BDGV0183.EUR","LU0127658192.USD","BK4597","LU2048586759.USD","LU1032955483.USD","LU1585245621.USD","LU1718418525.SGD","LU0949170772.SGD","BK4007","LU0795875169.SGD","LU0289739699.SGD","AMT","LU1316542783.SGD","LU1805238398.USD","LU0795875086.SGD","BK4177","SG9999001176.SGD","LU0210536198.USD","LU0234572021.USD","LU0354030438.USD","CTSH","BK4579","LU0175139822.USD","BK4141","LU0114720955.EUR","LU2129689431.USD","LU0553294199.USD","LU1989763005.USD","LU2756315318.SGD","IE0034235303.USD","LU0203345920.USD","BK4084","LU0868494708.USD","BK4134","BK4567","LU0702159699.USD","LU2931357623.SGD","LU0203347892.USD","LU1196500208.SGD","BK4551","BK4023","IE00BZ1G4Q59.USD","IE00BD6J9T35.USD","LU0231203729.USD","MUD","LU1803068979.SGD","LU1035775433.USD","LU1244550494.USD","LU2506952170.USD","BK4512","BK4519","LU0882574055.USD","LMT","LU0912757837.SGD","LU0345769631.USD","LU1267930813.SGD","LU0198837287.USD","LU1551013425.SGD","LU2403377893.USD","LU1323610961.USD","IE0001KFT4U8.USD","LU0640476718.USD","LU1032466523.USD","LU1861214812.USD","BK4548","LU1732800096.USD","BK4213","LU0354030511.USD","LU0210528500.USD","LU2089284900.SGD","LU2430703095.HKD","LU1861220033.SGD","LU0821914370.USD","LMTL","LU0889565833.HKD","LU2023250330.USD","PCTY","LU1057294990.SGD","LU1228905540.USD","IE00B3T34201.USD","IE00B5949003.HKD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU0096362180.USD","FUL","BK4568","LU1074936037.SGD","DRI","IE00BLSP4239.USD","LU0058720904.USD","LU2211815571.USD","LU1854104046.USD","LU0957808578.USD","LU1629891620.HKD","BK4554","LU1732799900.SGD","LU1153585028.USD","LU2456880835.USD","LU2089985449.USD","LU2347655156.SGD","LU2286300806.USD","BK4130","LU0053666078.USD","BK4605","LU0197229882.USD","LU1280957306.USD","LU1023059063.AUD","LU0820561818.USD","LU2023251221.USD","LU0426417589.USD","LU0345770993.USD","LU0823417737.USD","IE00BFXG1179.USD","LU0466842654.USD","AVAV","LU0536402901.SGD","LU0820561909.HKD","LU0545562505.USD","LU0348723411.USD","SYNA","IE00B3PB1722.GBP","LU2129689605.HKD","LU2111349929.HKD","LU1043141396.HKD","LU1974910355.USD","KYMR","LU1066051225.USD","LU1983260115.SGD","LU2089283258.USD","MRNA","LU0158827781.USD","LU2506952097.USD","LU1430594728.SGD","IE00BBT3K403.USD","LU0154245673.USD","IE00BVYPNV92.GBP","LU2543165471.USD","LU1778281490.HKD","LU1823568750.SGD","LU1043141123.HKD","LU0823417653.USD","AMAT","LU2505996681.GBP","LU2602419157.SGD","LU0476273544.USD","MUU","LU0345769128.USD","LU0724618433.USD","LU1815336091.USD","LU1983299246.USD","BK4532","LU0545039389.USD","LU1868836757.USD","BK4219","IE00BLSP4452.SGD","LMTS","LU1046421795.USD","LU2458330169.SGD","SNX","LU0097036916.USD","LU1048588211.SGD","LU0689626769.HKD","LU0738911758.USD","LU1244550577.SGD","LU2271345857.HKD","LU0642271901.SGD","LU2106854487.HKD","LU0792757196.USD","LU1166156734.SGD","LU0985320562.USD","LU2357305700.SGD","BK4147","INR","LU1145028129.USD","LU1861219969.SGD","LU1894683348.USD","LU0689472784.USD","LU1228905037.USD","BK4516","LU0234570918.USD","LU0098860793.USD","IE0009356076.USD","LU0274383776.USD","LU2417539215.USD","LU2413666699.HKD","BK4504","IE0009355771.USD","ON","LU2471134796.USD","IE00BFMHRM44.USD","MULL","LU2357627491.SGD","LU0661504455.SGD","SG9999001176.USD","LU1244550221.USD","LU2360106780.USD","LU2487616109.SGD","LU0957791311.USD","LU0124676726.USD","BK4604","LU1674673428.USD","MU","LU1642822529.SGD","LU0719512351.SGD","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155638133","title":"Sensei Biotherapeutics:Piktor治疗HR+/HER2-晚期乳腺癌的1B/2期中期数据预计2027年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1155638133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155638133?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布,其候选疗法Piktor针对HR阳性、HER2阴性晚期乳腺癌的1B/2期临床试验中期数据,预计将于2027年获得。该数据将提供关于疗法安全性及初步疗效的关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197135575","title":"Sensei Biotherapeutics:Piktor治疗晚期子宫内膜癌的II期关键数据预计2026年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1197135575","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197135575?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:12","pubTimestamp":1781525543,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics公司宣布,其候选药物Piktor针对晚期子宫内膜癌的II期临床试验关键性数据,预计将于2026年下半年公布。这一时间表为关注该疗法进展的投资者和医学界提供了明确的时间节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110665123","title":"Sensei Biotherapeutics任命Anand Parikh为董事长、总裁兼首席执行官,自2026年6月12日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1110665123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110665123?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:11","pubTimestamp":1781525508,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. (SNSE) 宣布,自2026年6月12日起,Anand Parikh将正式出任公司董事长、总裁兼首席执行官。此项任命标志着公司领导层的重要更迭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139331227","title":"Sensei Biotherapeutics更名为Faeth Therapeutics,全力推进口服抗癌疗法Piktor","url":"https://stock-news.laohu8.com/highlight/detail?id=1139331227","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139331227?lang=zh_cn&edition=fundamental","pubTime":"2026-06-15 20:10","pubTimestamp":1781525426,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics, Inc. 宣布将公司名称变更为Faeth Therapeutics。这一更名标志着公司战略重心聚焦于推进其核心候选药物Piktor的研发。Piktor是一种口服疗法,旨在靶向癌症中最常发生异常改变的信号通路之一。公司此举旨在更好地反映其专注于开发变革性癌症治疗药物的新方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}